Clinical trial
Tenecteplase Thrombolysis for Acute Ischemic Stroke in the 4.5-9-Hour Window Guided by DWI-FLAIR Mismatch: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
NCT07540416 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Zhengzhou University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tenecteplase Thrombolysis for Acute Ischemic Stroke in the 4.5-9-Hour Window Guided by DWI-FLAIR Mismatch: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
- Lead sponsor
- The First Affiliated Hospital of Zhengzhou University
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- May 1, 2026
- Completion date
- June 30, 2028
- Enrollment
- 564 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute ischemic stroke